Electrical Monitoring Tracked Cell Health in Biomanufacturing
Researchers demonstrated that electrical signatures can predict cellular apoptosis, enabling automated bioprocessing.
Updated on Oct. 7, 2026 in Biotech
Live Poll
Do you trust automated machine learning systems to manage quality in pharmaceutical manufacturing?
A review of research conducted from 2015 through 2026 detailed how dielectrophoresis tracks cellular electrical signatures to monitor health without labels or cell destruction. The study highlighted that integrating these measurements with machine learning models allows for automated batch monitoring in biomanufacturing.
Why it matters
Real-time monitoring is currently a major bottleneck in biologics manufacturing because conventional methods only provide delayed snapshots of cell status. Automating these diagnostics with electrical impedance data could enable autonomous intervention and optimized harvesting.
A 3DEP platform captures electrical signatures from roughly 20,000 cells within seconds, detecting a conductivity drop from 0.45 siemens per meter in viable cells to 0.05 siemens per meter during apoptosis. The random-forest model achieved 90% predictive accuracy for batch monitoring.
The players
Alaleh Vaghef-Koodehi
A researcher at the University of Massachusetts Amherst focused on advances in electrical cell monitoring and bioprocessing.
Blanca Lapizco-Encinas
A co-author based at the Rochester Institute of Technology specializing in dielectrophoresis and microfluidic technologies.
The details
Dielectrophoresis is a technique that uses nonuniform electric fields—electric fields that vary in intensity across space—to move particles based on their polarizability and electrical signatures. By measuring cytoplasmic conductivity, researchers can identify when Chinese hamster ovary cells undergo nutrient-starvation-induced apoptosis, a process of programmed cell death. A 2026 study integrated this electrical impedance data into a supervised machine learning model to automate health assessments.
Timeline
2015-2026: Period covered by the review of electrical monitoring advances.
24-36 hours: Timeframe for the emergence of apoptotic cell populations.
52 hours: Time point where cytoplasmic conductivity reached 0.07 S/m.
2026: Year the machine learning model achieved 90% predictive accuracy.
The Tech Race
This development moves beyond current batch-monitoring benchmarks that rely on static, offline sampling methods. It establishes a path for real-time, sensor-driven oversight in large-scale biologic production lines.
This technology aims to improve the consistency and reliability of biomanufacturing workflows, potentially lowering costs for mass-produced biologics. Widespread industry adoption depends on the transition of these machine learning models into closed-loop, automated hardware systems.
The takeaway
Electrical signatures provide a high-fidelity, non-destructive window into cell health that could replace slow, manual lab assays. Watch for future integration of random-forest models into automated bioreactor controls for real-time yield optimization.
Further reading
Explore more on the current state of industrial Biotech.
Source note: This article includes information reported by GEN - Genetic Engineering and Biotechnology News.
Live Poll
Do you trust automated machine learning systems to manage quality in pharmaceutical manufacturing?
